patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: PSTI Annual Meeting

Dear Valued Customer,

You elected to receive shareholder communications and submit voting instructions via
the Internet. This e-mail contains information specific to your holding in the securities
identified below.

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting

2013 PLURISTEM THERAPEUTICS, INC. is holding an Annual Meeting of Stockholders as follows:

MEETING DATE: May 21, 2013

Share
New Message
Please login to post a reply